Month: December 2017
-
Super High-Resolution Photo Sensor Developed
Engineers at Dartmouth College developed a sensor that captures light signals at high speed and resolution down to the level of individual photons.
-
Agriculture Tech Start-Up Accelerator to Open
A group supporting start-up companies and entrepreneurs developing new technologies in food and agriculture plans to begin next month in Minneapolis, Minnesota.
-
Biotechs Partner on HPV Cancer Immunotherapies
Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV.
-
FDA Issues Draft Precision Medicine Trial Guidance
The U.S. Food and Drug Administration issued draft regulatory guidance on clinical trials for new treatments that target genetic mutations rather than disease states.
-
Reading Vital Signs with Radio Waves Designed
Engineers at Cornell University developed techniques for reading a person’s key health indicators with plastic tags and radio waves instead of the specialized devices used today.
-
FDA Fast-Tracks Heart Failure Gene Therapy
A biotechnology company developing transfers of healthy genes to treat chronic diseases is receiving an accelerated review of its heart failure therapy from the U.S. Food and Drug Administration.
-
Current Drug Helps Cut Opioid Use After Surgery
Results from a clinical trial show patients given a current non-opioid pain medication with different types of surgery were less likely to use opioids for up to a year later.
-
Mobile Apps for Eating Disorders in Development
Two mobile device apps are being developed focusing on behavioral factors related to eating that can lead to unhealthy outcomes.
-
MIT Building Statewide Health Innovation System
A unit of Massachusetts Institute of Technology is establishing what it calls an innovation ecosystem that pulls together different players in health care to better serve the needs of patients.
-
Consortium to Speed, Expand Alzheimer’s Clinical Trials
A group of medical centers is establishing a network of clinical trial sites and processes for testing new treatments for Alzheimer’s disease.